Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
521 17. Excellent absorption enhancing characteristics of No Donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers. 2006
522 Physicochemical characterization of ibuprofen/hypromellose acetate succinate solid dispersions. 2006
523 18. Colon-Specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives. 2006
524 18. Colon-Specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives. 2006
525 18. Colon-Specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives. 2006
526 Improvement of absorption enhancing effects of n-dodecyl-β-D- maltopyranoside by its colon-specific deliver using chitosan capsules. 2005
527 Pharmacokinetic analysis of the tissue distribution of octaarginine modified liposomes in mice. 2005
528 Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. 2005
529 Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. 2005
530 Pharmacological evidence for the role of nitric oxidecGMP in antinociception 2005